|
|
.
NPI Detail
NPI: 1851370910
Type: Organization
Taxonomy Code: 251S00000X
3400 XXXXXX XX
PHILADELPHIA, PA 191044206
Mailing and Business location phone:
(XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1851370910*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 36415
|
ROUTINE VENIPUNCTURE
|
XXXXX
|
$XXXXXX.XX
|
| 80053
|
COMPREHEN METABOLIC PANEL
|
XXXXX
|
$XXXXXX.XX
|
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXXX.XX
|
| 88305
|
TISSUE EXAM BY PATHOLOGIST
|
XXXXX
|
$XXXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J1642
|
Inj heparin sodium per 10 u
|
XXXXXX
|
-
|
| J9271
|
Inj pembrolizumab
|
XXXXXX
|
$XXXXXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J2704
|
Inj, propofol, 10 mg
|
XXXXXX
|
-
|
| J8540
|
Oral dexamethasone
|
XXXXXX
|
-
|
| J1453
|
Fosaprepitant injection
|
XXXXXX
|
$XXXXX.XX
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXXX
|
$XXXXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXXX
|
-
|
| J9176
|
Injection, elotuzumab, 1mg
|
XXXXXX
|
$XXXXXX.XX
|
| J1756
|
Iron sucrose injection
|
XXXXXX
|
-
|
| J2350
|
Injection, ocrelizumab, 1 mg
|
XXXXXX
|
$XXXXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXXX
|
-
|
| J0897
|
Denosumab injection
|
XXXXXX
|
$XXXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXXX
|
$XXXXXX.XX
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXXX
|
$XXXXXX.XX
|
| J9025
|
Azacitidine injection
|
XXXXX
|
$XXXXX.XX
|
| J1569
|
Gammagard liquid injection
|
XXXXX
|
$XXXXXXX.XX
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J7195
|
Factor ix recombinant nos
|
XXXXX
|
$XXXX.XX
|
| J3380
|
Injection, vedolizumab
|
XXXXX
|
$XXXXXX.XX
|
| J2370
|
Phenylephrine hcl injection
|
XXXXX
|
-
|
| J0585
|
Injection,onabotulinumtoxina
|
XXXXX
|
$XXXXXX.XX
|
| J9305
|
Inj. pemetrexed nos 10mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9035
|
Bevacizumab injection
|
XXXXX
|
$XXXXXXX.XX
|
| J0485
|
Belatacept injection
|
XXXXX
|
$XXXXXX.XX
|
| J9312
|
Inj., rituximab, 10 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J2001
|
Lidocaine injection
|
XXXXX
|
-
|
| J7193
|
Factor ix non-recombinant
|
XXXXX
|
$XXXX.XX
|
| J0896
|
Inj luspatercept-aamt 0.25mg
|
XXXXX
|
$XXXXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXXXX
|
$XXXXXXX.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
